Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02832284 · ClinicalTrials.gov registry record · NA
iNod System Human Feasibility Assessment
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02832284 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 23 participants.
The verdict
NCT02832284, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate feasibility to access, visualize, and obtain specimens adequate for cytology of lung lesions in subjects with suspected lung cancer when using the iNod System.
Interventions
- DEVICE iNod System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-01-18 |
| Est. Completion | 2017-06-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02832284
The ClinicalTrials.gov registry entry for NCT02832284 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iNod System is the first listed.
NCT02832284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02832284 about?
NCT02832284 is a clinical study titled "iNod System Human Feasibility Assessment". The purpose of this study is to demonstrate feasibility to access, visualize, and obtain specimens adequate for cytology of lung lesions in subjects with suspected lung cancer when using the iNod System.
What is the current status of trial NCT02832284?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2017-01-18. Estimated completion is 2017-06-14.
What interventions are being tested in trial NCT02832284?
The interventions under investigation include: iNod System (DEVICE).
Who is sponsoring clinical trial NCT02832284?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.